Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 7/20 | 0.83 |
| ▸ | NADK | O95544 | 1/20 | 0.83 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.74 |
| ▸ | DNMT3B | Q9UBC3 | 2/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.74 |
| ▸ | PNMT | P11086 | 1/20 | 0.74 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.74 |
| ▸ | DPP4 | P27487 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.74 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.74 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.74 |
| ▸ | GAPDH | P04406 | 1/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.74 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.74 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.74 |
| ▸ | STAT6 | P42226 | 1/20 | 0.74 |
| ▸ | PI4KA | P42356 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylthioadenosine SCHEMBL29439558 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL20798030 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL160358 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL29361072 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL890628 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL31388809 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL11954365 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL10013421 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL7124285 | 0.95 | DOT1L (0.78) | AHCYNADKDOT1LDNMT3BPNMT | |
| Methylthioadenosine SCHEMBL20817193 | 0.91 | AHCY (0.70) | AHCYNADKDOT1LDNMT3BADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144829-A1 | SYNBIOTIC COMPOSITION, METABOLITES, AND METHOD OF PREVENTING AND TREATING OBESITY-RELATED DISEASE | Hsu, Cheng-Chih (TW) | 2026-05-28 | — | — | US | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | FRESENIUS MEDICAL CARE HOLDINGS, INC. (US) | 2026-02-19 | — | — | US | claimed |
| US-20250341515-A1 | METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | US | claimed |
| EP-4597111-A1 | USE OF METABOLIC MARKER FOR DIAGNOSIS OF LUNG CANCER STAGING AND KIT | Harbin Metanotitia Inc. (CN) | 2025-08-06 | — | — | EP | claimed |
| WO-2025085615-A1 | METHODS TO RAPIDLY DETECT METHYLTHIOADENOSINE AND RELATED METABOLITES DIRECTLY FROM PATIENT SAMPLES TO IDENTIFY 9P21 LOSS CANCERS AND TREATMENT STRATEGIES FOR PATIENTS | BAYLOR COLLEGE OF MEDICINE (US) | 2025-04-24 | — | — | WO | claimed |
| US-20240385183-A1 | METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS | NORTHWESTERN UNIVERSITY | 2024-11-21 | — | — | US | claimed |
| WO-2024230650-A1 | SYNBIOTIC COMPOSITION, METABOLITE AND USE THEREOF IN PREVENTION AND TREATMENT OF OBESITY-RELATED DISEASES | 徐丞志 | 2024-11-14 | — | — | WO | claimed |
| WO-2024152730-A1 | BIOMARKERS FOR IDENTIFYING INFREQUENT GOUT FLARES AND FREQUENT GOUT FLARES AND USE THEREOF | 苏州艾麦锶生命科技有限公司 | 2024-07-25 | — | — | WO | claimed |
| US-12018299-B2 | Methods and kits for quantifying adenosine-containing molecules | SEVIVO LLC (US) | 2024-06-25 | — | — | US | claimed |
| EP-0505440-A4 | GENETIC CONTROL OF ETHYLENE BIOSYNTHESIS IN PLANTS | — | 1992-11-19 | — | — | EP | claimed |
| EP-0505440-A1 | GENETIC CONTROL OF ETHYLENE BIOSYNTHESIS IN PLANTS | AGRITOPE, INC. (US) | 1992-09-30 | — | — | EP | claimed |
| WO-1992007570-A1 | AGENTS FOR THE TREATMENT OF DISEASES CAUSED BY PARASITIC PROTOZOA AND NEOPLASTIC DISEASES | HEALTH RESEARCH, INC. (US) | 1992-05-14 | — | — | WO | claimed |
| WO-1991009112-A1 | GENETIC CONTROL OF ETHYLENE BIOSYNTHESIS IN PLANTS | AGRITOPE, INC. (US) | 1991-06-27 | — | — | WO | claimed |
| US-4973678-A | VASODILATORS, ANALGESICS, ANTIINFLAMMATORY, ANTIPYRETIC, ANTICOAGULANTS | NB JACKETS DE PUERTO RICO (US) | 1990-11-27 | — | — | US | claimed |
| EP-0387757-A2 | Use of 5'-deoxy-5'methylthioadenosine, S-adenosylmethionine and their salts in the preparation of pharmaceutical compositions favouring hair growth in subjects suffering from baldness | BIORESEARCH S.p.A. (IT) | 1990-09-19 | — | — | EP | claimed |
| EP-0387756-A1 | Use of 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions | BIORESEARCH S.p.A. (IT) | 1990-09-19 | — | — | EP | claimed |
| EP-0184248-B1 | SALTS OF 5'-METHYLTHIO-5'-DEOXYADENOSINE WITH LONG-ALKYL CHAIN SULPHONIC ACIDS | BIORESEARCH S.p.A. (IT) | 1989-08-02 | — | — | EP | claimed |
| EP-0184248-A2 | Salts of 5'-methylthio-5'-deoxyadenosine with long-alkyl chain sulphonic acids | BIORESEARCH S.p.A. (IT) | 1986-06-11 | — | — | EP | claimed |
| US-4373097-A | Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity | BIORESEARCH S.R.L. (IT) | 1983-02-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144829-A1 | SYNBIOTIC COMPOSITION, METABOLITES, AND METHOD OF PREVENTING AND TREATING OBESITY-RELATED DISEASE | MLN, COMT, MLEC | AHCY 77/4885NADK 2095/4885DOT1L 2329/4885 |
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | SLC43A1, SLC14A1, SLC1A5 | AHCY 183/4885NADK 2614/4885DOT1L 3430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.